Analystreport

Blueprint Medicines Co. (NASDAQ: BPMC) had its price target lowered by analysts at SVB Leerink LLC from $82.00 to $60.00. They now have a "market perform" rating on

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com